# Contribution of New Pancreatic MRI Sequences for the Evaluation of Tumor Response in Pancreatic Adenocarcinomas

> **NCT06842303** · NA · RECRUITING · sponsor: **Central Hospital, Nancy, France** · enrollment: 120 (estimated)

## Conditions studied

- Pancreas Adenocarcinomas

## Interventions

- **DEVICE:** Magnetic resonance elastography (MRE).
- **DEVICE:** High-resolution diffusion sequence in MRI

## Key facts

- **NCT ID:** NCT06842303
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-06
- **Primary completion:** 2027-06-06
- **Final completion:** 2027-06-06
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06842303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06842303, "Contribution of New Pancreatic MRI Sequences for the Evaluation of Tumor Response in Pancreatic Adenocarcinomas". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06842303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*